Endotronix
Company

Last deal

$70M

Amount

Series D

Stage

14.09.2018

Date

10

all rounds

$129.6M

Total amount

General

About Company
Endotronix develops hemodynamic monitoring technologies to detect worsening heart failure earlier.

Industry

Sector :

Subsector :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company's platform includes a cloud-based disease management data system and an outpatient hemodynamic management tool with a wireless pulmonary artery sensor. This allows patients to detect worsening heart failure at home, which promotes ongoing therapeutic interventions and reduces hospital readmissions. Endotronix's integrated platform provides comprehensive, reimbursable health management tools for patients suffering from advanced heart failure, enabling health professionals to streamline patient management and drive meaningful clinical and economic outcomes.
Contacts

Phone number

Social url